Breaking News


Malignancy concerns with various psoriasis treatments: a review


A review of facts and controversies relating to malignancy risk in patients with psoriasis, both independent of medication exposure and following specific therapies, has been published. The risk of psoriasis is known to be increased in smokers and those with a high body mass index (BMI), and thus it is not surprising that selected cancers linked to smoking and obesity have also been linked to psoriasis. Regarding treatment-specific risks with oral psoralen and UVA light (PUVA), an elevenfold greater risk of squamous cell carcinoma (SCC) was seen in patients who had received > 260 PUVA treatments over 10 years. A modest increase in basal cell carcinoma was also seen and a ...

to Continue Reading, Login Now

Please Login

If you are a registered user but you have forgotten your password, please click here
If you are not a registered user, please register here

return to breaking news list